| Join the launch of the Together4RD Toolkit for Public-Private Partnerships in Rare Disease Research |
2025-06-23 |
17:00 hr |
Maurizio Scarpa, Daria Julkowska and Victoria Hedley |
|
|
| Together for Rare Diseases & ERICA Webinar |
2025-01-16 |
17:00 – 17:45 hr |
|
|
|
| Together for Rare Diseases & ERICA Webinar about ERNs for Industry partners |
2024-12-02 |
17:00 – 17:45 hr |
Alberto Pereira, Franz Schäfer, Katarzyna Mosiewicz and Sheela Upadhyaya |
|
|
| Disease Specific Measures |
2024-07-24 |
15:00 – 16:30 hr |
Tanja Wlodkowski, Faisal Ahmed, Ana Priego Zurita and Johan de Graaf |
|
|
| c4c expert advice, patient and public involvement, data standards |
2024-05-03 |
13:00 – 14:00 hr |
Mark Turner, Fenna Mahler, Pamela Dicks and Becca Leary |
|
|
| Approaches to the Evaluation of Evidence for Rare Disease and Complex Conditions Guidelines |
2024-04-29 |
14:00 – 15:30 hr |
|
|
|
| c4c trials, education and training |
2024-04-11 |
13:00 – 14:00 hr |
Mark Turner, Chloe Bickerstaff, Francesca Rocchi and Becca Leary |
|
|
| EMA Webinar on Rare World Diseases Day |
2024-02-29 |
16:00 – 17:25 hr |
Kristina Larsson, Virginie Hivert, Melanie Carr, Hélène Le Borgne, Theodor Framke, Violeta Stoyanova-Beninska, Iordanis Gravanis, Maria Mavris and Maribel Rico-Salas |
|
|
| Transitioning trials to the CTR (CTIS) for non-commercial sponsors |
2024-02-09 |
10:00 – 13:00 hr |
|
|
|
| “Bridging the gap between promising preclinical data and a successful clinical trial” |
2023-10-19 |
16:00 – 17:00 hr |
Gilles Vassal and Joanne Lee |
|
|
| REMEDI4ALL / drug repurposing and clinical trial readiness by Anton Ussi |
2023-10-02 |
13:00 – 14:00 hr |
Anton Ussi |
|
|
| Framework for Patient Engagement in Clinical Trials |
2023-05-24 |
15:00 – 16:00 hr |
Virginie Hivert and María Cavaller Bellaubi |
|
|
| Introduction on Patient-Reported Outcomes and considerations before including them in a clinical trial. Study case from the ERN-EuroBloodNet |
2023-05-10 |
12:30 – 13:30 hr |
Céline Desvignes-Gleizes, Andreas Glenthøj and Dore Peereboom |
|
|
| Designing and conducting clinical trials in rare diseases – what industries expect for partnering with clinical sites |
2023-04-14 |
12:30 – 13:30 hr |
Diego Ardigò |
|
|
| Definition of orphan drug by the EMA |
2023-03-28 |
12:30 – 13:30 hr |
Armando Magrelli |
|
|
| Essential requirements before thinking about a clinical trial |
2023-02-28 |
12:00 – 13:00 hr |
Viviana Giannuzzi |
|
|
| Joint HMA/EMA Multi-stakeholder workshop on Patient Registries 12&13 February 2024 |
2023-02-12 |
|
|
|
|
| WP5 Educational Webinar 2 “Practical guide on how to use the Catalogue of services and the IMT” |
2022-10-24 |
13:00 – 14:00 hr |
Anton Ussi, Agustin Arasanz Duque and Rosan Vegter |
|
|
| Composite endpoints including patient relevant endpoints (Quality of Life) |
2022-05-06 |
16:00 – 18:30 hr |
Johan Verbeeck |
|
|
| EMA Virtual meeting Repurposing ‘WALK-IN’ CLINIC |
2022-02-17 |
17:00 – 18:30 hr |
|
|
|
| Does Randomization matter in RD clinical trials? |
2021-12-14 |
|
Ralf-Dieter Hilgers |
|
|
| EMA Webinar for SMEs and Academia on the Clinical Trials Regulation and the Clinical Trials Information System |
2021-11-29 |
9:00 – 13:30 hr |
|
|
|
| Educational Webinar 1 Current research services available for the rare diseases community |
2021-11-08 |
15:00 – 16:00 hr |
Anton Ussi |
|
|